Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial (Q39382188)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

Chikungunya virus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Philippe Desprès

7

object named as

Philippe Desprès

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

9

object named as

Bernd Jilma

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Michael Schwameis

2

object named as

Michael Schwameis

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Katrin Ramsauer

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Christa Firbas

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Matthias Müllner

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Robert J Putnak

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Stephen J Thomas

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Erich Tauber

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Frederic Tangy

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

2 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

519-527

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

on focus list of Wikimedia project

0 references

Chikungunya in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chikungunya virus infections among travelers-United States, 2010-2013.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chikungunya at the door--déjà vu all over again?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High efficiency of temperate Aedes albopictus to transmit chikungunya and dengue viruses in the Southeast of France

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chikungunya virus and arthritic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical burden of chikungunya virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and impaired quality of life 30 months after chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chikungunya virus, epidemiology, clinics and phylogenesis: A review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chikungunya virus and prospects for a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chikungunya: a paradigm of emergence and globalization of vector-borne diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of an attenuated strain of chikungunya virus for use in vaccine production

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-sided confidence intervals for the single proportion: comparison of seven methods by Robert G. Newcombe, Statistics in Medicine 1998; 17:857-872.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating the burden of disease and the economic cost attributable to chikungunya, Andhra Pradesh, India, 2005-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preparedness for threat of chikungunya in the pacific

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chikungunya, an epidemic arbovirosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970043-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(15)70043-5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39382188&oldid=1823607979"